Cytosorbents Crp (CTSO) — Financial Flexibility Index
Cytosorbents Crp (CTSO) has a Financial Flexibility Index of -0.04x as of June 2026. Free cash flow of $-1.72 Million (operating CF $-1.75 Million minus capex $25.00K) represents 0% of total liabilities ($38.71 Million). Check CTSO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytosorbents Crp Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Cytosorbents Crp across 22 annual periods. For the full cash flow conversion analysis, see Cytosorbents Crp (CTSO) cash conversion ratio.
Annual Financial Flexibility Index for Cytosorbents Crp (2004–2025)
Year-by-year free cash flow to debt coverage for Cytosorbents Crp. Explore Cytosorbents Crp cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.32x | $-12.21 Million | $-12.38 Million | $38.28 Million | ▲ +18.2% |
| 2024 | -0.39x | $-14.14 Million | $-14.43 Million | $36.26 Million | ▲ +43.6% |
| 2023 | -0.69x | $-20.72 Million | $-21.66 Million | $29.99 Million | ▲ +11.6% |
| 2022 | -0.78x | $-21.78 Million | $-28.23 Million | $27.86 Million | ▼ -116.6% |
| 2021 | -0.36x | $-9.72 Million | $-14.01 Million | $26.94 Million | ▲ +1.6% |
| 2020 | -0.37x | $-3.94 Million | $-5.61 Million | $10.73 Million | ▲ +42.3% |
| 2019 | -0.64x | $-15.24 Million | $-16.76 Million | $23.96 Million | ▼ -7.9% |
| 2018 | -0.59x | $-9.32 Million | $-10.84 Million | $15.81 Million | ▼ -70.6% |
| 2017 | -0.35x | $-4.78 Million | $-6.46 Million | $13.84 Million | ▲ +42.7% |
| 2016 | -0.60x | $-6.14 Million | $-6.73 Million | $10.17 Million | ▲ +78.0% |
| 2015 | -2.75x | $-8.37 Million | $-9.01 Million | $3.04 Million | ▼ -96.8% |
| 2014 | -1.40x | $-6.29 Million | $-6.66 Million | $4.51 Million | ▼ -681.5% |
| 2013 | -0.18x | $-3.27 Million | $-3.49 Million | $18.31 Million | ▲ +25.2% |
| 2012 | -0.24x | $-3.58 Million | $-3.62 Million | $14.96 Million | ▲ +88.6% |
| 2011 | -2.09x | $-3.78 Million | $-3.83 Million | $1.80 Million | ▼ -107.9% |
| 2010 | -1.01x | $-2.31 Million | $-2.48 Million | $2.30 Million | ▲ +63.3% |
| 2009 | -2.74x | $-2.66 Million | $-2.67 Million | $970.76K | ▼ -20.2% |
| 2008 | -2.28x | $-2.34 Million | $-2.37 Million | $1.03 Million | ▲ +20.3% |
| 2007 | -2.86x | $-2.59 Million | $-2.63 Million | $906.87K | ▼ -11.2% |
| 2006 | -2.57x | $-2.78 Million | $-2.85 Million | $1.08 Million | ▼ -424.8% |
| 2005 | -0.49x | $-50.00K | $-50.00K | $101.97K | ▲ +11.7% |
| 2004 | -0.56x | $-50.00K | $-50.00K | $90.00K | — |